Patents
NeuroCuple® is built on a foundation of patented nanotechnology designed to safely and effectively relieve pain without drugs or invasive procedures.
These innovations, enable the NeuroCuple® device to interact with the body's natural energy and pain signals, providing long-lasting, reusable pain relief.
Below are the core patents protecting and powering the NeuroCuple® technology:
🧾 2020 - U.S. Patent No. 10,707,570
Title: Techniques for Pain Relief
This foundational patent covers the system’s unique layered construction and interaction with biologically-generated AC signals. It is central to the NeuroCuple®'s safe, passive operation.
🧾 2022 - U.S. Patent No. 11,380,985
Title: Techniques for Pain Relief
This invention details methods of creating multilayer nanostructures that disrupt pain signals noninvasively. It supports the core functionality of reusable, drug-free relief with zero consumables.
🧾 2024 - U.S. Patent No. 11,967,761
Title: Techniques for Pain Relief
This patent outlines advanced material designs that interact with localized energy fields to reduce pain without requiring external power or heat. It's key to the energy-based function of the NeuroCuple® system.
🧾 2026 - U.S. Patent No. 12,646,830
Title: Techniques for Pain Relief
This patent expands and strengthens the NeuroCuple® intellectual property portfolio by protecting additional methods, materials, and system configurations used in passive, non-powered pain relief technology. It reinforces the unique ability of NeuroCuple® devices to interact with the body's natural bioelectrical environment without drugs, batteries, electrical stimulation, or invasive procedures, supporting broader applications in pain management, recovery, rehabilitation, and wellness.
Why These Patents Matter
The NeuroCuple® patent portfolio protects a unique approach to non-invasive pain relief that does not rely on drugs, batteries, electrical stimulation, heating elements, or consumable components. These patents cover the materials, structures, manufacturing methods, and techniques used to create reusable pain relief devices designed to interact with the body's natural bioelectrical environment. Together, these innovations form the foundation of NeuroCuple® technology and help ensure long-term product quality, consistency, and continued advancement.
About NeuroCuple® Technology
NeuroCuple® technology is a passive nano-capacitive platform developed to provide drug-free pain relief without external power sources. The technology is incorporated into lightweight, reusable devices that can be placed near areas of discomfort and used during normal daily activities. NeuroCuple® products have been used by millions of people worldwide and have been the subject of multiple clinical investigations examining pain reduction, opioid reduction, recovery support, and functional outcomes.
From Patent to Clinical Research
The patented NeuroCuple® platform has been evaluated in clinical studies involving postoperative pain, musculoskeletal pain, opioid reduction, and functional recovery. Published research and ongoing investigations continue to explore the role of passive nano-capacitive technology in supporting pain management without drugs, batteries, or invasive procedures.
The NeuroCuple® device is the result of years of research and innovation. To explore the latest clinical data, visit our corporate site ncapmedical.com.
Invented by Rhett F. Spencer
NeuroCuple® technology was invented by Rhett Spencer and has evolved through multiple generations of research, development, and patent protection. The growing patent portfolio reflects ongoing innovation in passive, non-powered approaches to pain relief and bioelectrical interaction technologies.
Patent Portfolio at a Glance
| Patent |
Granted |
Focus |
| 10,707,570 |
2020 |
Foundational NeuroCuple architecture |
| 11,380,985 |
2022 |
Advanced multilayer structures |
| 11,967,761 |
2024 |
Enhanced material configurations |
| 12,646,830 |
2026 |
Expanded system designs and methods |
